BCM
AGN

Beck Capital Management’s Allergan plc AGN Stock Holding History

Beck Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,339
Closed -$333K – 109
2017
Q2 		$333K Sell
1,339
-271
-17% -$63.7K 0.17% 81
2017
Q1 		$385K Buy
+1,610
New +$375K 0.2% 77

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Beck Capital Management's AGN Position: Q3 2017 in Review

Beck Capital Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,339 shares — an estimated $333K sold.

Beck Capital Management first reported a position in AGN in Q1 2017 and held it in 2 quarters. The position peaked at $385K in Q1 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Beck Capital Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Beck Capital Management sold 1,339 Allergan plc shares in Q3 2017, an estimated $333K.
  • Beck Capital Management first reported a position in Allergan plc in Q1 2017 and held it in 2 quarters.
  • Beck Capital Management's Allergan plc position peaked at $385K in Q1 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Beck Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.